# Fennec Pharmaceuticals Inc.: Form DEF 14A, filed May 13, 2024

- Company: [Fennec Pharmaceuticals Inc.](/companies/fenc.md) (CIK 1211583)
- Form: DEF 14A
- Filed: 2024-05-13
- Accepted by EDGAR: May 13, 2024, 16:42 ET
- Period: 2024-06-25
- Accession: 0001558370-24-007979
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1211583/000155837024007979/tmb-20240625xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1211583/000155837024007979/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1211583/000155837024007979/tmb-20240625xdef14a.htm

Filed May 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-007979. Last ingested by Listed: Nov 2, 2026, 19:14 ET. No prices; not investment advice.